Mary Wade Healthcare bonds cut to CCC+ as losses strain liquidity

Traders Union
All News
Financial News
Mary Wade bonds downgrade

Highlights

Fitch downgrades Mary Wade Healthcare's Issuer Default Rating and related bonds to 'CCC+' from 'B-' due to sustained operating losses and increased default risk.
Endowment declines to $13.2 million by fiscal year-end 2025 from $21.9 million in 2020, with unrestricted cash and investments dropping to $13.2 million and 190 days cash on hand.
Fitch highlights persistent cost pressures, 102.6% operating ratio, continued heavy reliance on government payors, and warns that further negative rating action is possible if losses persist.

Downgrade reflects rising default risk

As reported by Fitch Ratings, Mary Wade Healthcare's Issuer Default Rating is downgraded to 'CCC+' from 'B-', and revenue bonds issued by the State of Connecticut Health and Educational Facilities Authority on behalf of the provider are also lowered to 'CCC+'. Fitch says the move reflects a material level of default risk after large operating losses in every fiscal year since 2021 and a decline in financial flexibility.

The ratings agency says the organization's endowment falls to $13.2 million at fiscal year-end 2025 from $21.9 million at fiscal year-end 2020, largely because funds are drawn to support the minimum 1.2x debt service coverage ratio amid continuing losses. The bonds are secured by a gross revenue pledge of the obligated group, a first mortgage and security interest in all assets of the group, and a debt service reserve fund.

Fitch says management plans to increase assisted living unit occupancy and contain costs, but it expects significant headwinds and continuing operating pressure. Its base case assumes operations improve gradually to near break-even over the next several years, with capital spending remaining broadly in line with fiscal 2025 levels.

Payor mix and occupancy remain key pressures

Mary Wade Healthcare remains heavily exposed to skilled nursing facility revenue and government reimbursement, factors that Fitch views as a structural constraint on pricing flexibility and operating performance. Skilled nursing accounts for 63% of fiscal 2025 revenue, improved from 82% in fiscal 2021, but Medicaid still makes up 70% of net skilled nursing revenue in fiscal 2025.

The provider's 2021 expansion adds 84 private-pay units, including 64 assisted living units and 20 memory care units, which could reduce reliance on government payors over time. The expansion begins to fill in February 2022, while Fitch notes demand has stayed strong for the skilled nursing facility, with occupancy above 90% for the past several years and limited local competition supporting demand.

Cost pressures remain difficult to offset because assisted living, memory care and skilled nursing operations are labor intensive and offer limited ability to pass through higher expenses. Fitch calculates a fiscal 2025 operating ratio of 102.6% including ERC funds and 113.4% excluding them, while unrestricted cash and investments stand at $13.2 million, equal to 190 days cash on hand and 28.8% cash-to-adjusted debt, down from $22 million, 533 days and 55% in fiscal 2020. Fitch says further negative pressure could follow if cost controls fail to reduce losses, occupancy does not improve, or bond covenant compliance weakens, while positive rating action is unlikely in the near term.

Our earlier article on Fitch affirming Bank of Ireland (UK) plc’s 'A+' Long-Term Issuer Default Rating outlined how the Stable Outlook was supported by strong parental backing, solid capital and funding, and broadly resilient asset quality. We also noted that, despite the shift toward higher-margin UK lending, the bank faced longer-term profitability pressures from limited diversification and potential margin tightening as rates fall.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.